Literature DB >> 19032413

Possible transfer of vitiligo by allogeneic bone marrow transplantation: a case report.

Fethi Mellouli1, Habib Ksouri, Nawel Dhouib, Lamia Torjmen, Abderrahman Abdelkefi, Saloua Ladeb, Tarek Ben Othman, Slama Hmida, Assia Ben Hassen, Mohamed Béjaoui.   

Abstract

Among the cases yet published of development of vitiligo after BMT, only two can claim as possible adoptive transfer of such disease. We report a case of a patient with sickle cell disease in whom vitiligo developed after allogeneic BMT from his HLA identical father affected by vitiligo. We reviewed and searched for some particularities in the reported cases of post-BMT vitiligo.

Entities:  

Mesh:

Year:  2009        PMID: 19032413     DOI: 10.1111/j.1399-3046.2008.01093.x

Source DB:  PubMed          Journal:  Pediatr Transplant        ISSN: 1397-3142


  4 in total

Review 1.  Vitiligo following stem-cell transplant.

Authors:  Alessio Totani; Hossam Amin; Stephen Bacchi; Ian Lewis
Journal:  Bone Marrow Transplant       Date:  2019-07-29       Impact factor: 5.483

2.  Risk factors and characterization of vitiligo and alopecia areata in patients with chronic graft-vs-host disease.

Authors:  Rena C Zuo; Haley B Naik; Seth M Steinberg; Kristin Baird; Sandra A Mitchell; Zoya Kuzmina; Steven Z Pavletic; Edward W Cowen
Journal:  JAMA Dermatol       Date:  2015-01       Impact factor: 10.282

3.  Successful Repigmentation of Vitiligo after Allogeneic Bone Marrow Transplantation for Hodgkin's Lymphoma by Autologous Noncultured Melanocyte-keratinocyte Transplantation.

Authors:  Huijuan Tang; Cui Wang; Lifang Fu; Ai-E Xu
Journal:  Indian J Dermatol       Date:  2015 Sep-Oct       Impact factor: 1.494

4.  High frequency of cutaneous manifestations including vitiligo and alopecia areata in a prospective cohort of patients with chronic graft-vs-host disease.

Authors:  Romana Čeović; Lana Desnica; Dražen Pulanić; Ranka Serventi Seiwerth; Ivana Ilić; Magdalena Grce; Marinka Mravak Stipetić; Tajana Klepac Pulanić; Ervina Bilić; Ernest Bilić; Milan Milošević; Radovan Vrhovac; Damir Nemet; Steven Z Pavletic
Journal:  Croat Med J       Date:  2016-06-30       Impact factor: 1.351

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.